Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Meningioma 1 (MN1) contains two sets of CAG repeats. Additionally we are shipping MN1 Proteins (3) and and many more products for this protein.
Showing 10 out of 37 products:
Human Polyclonal MN1 Primary Antibody for EIA, WB - ABIN953469
Kandilci, Grosveld: Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation. in Blood 2009
Show all 5 references for ABIN953469
Human Polyclonal MN1 Primary Antibody for ELISA, WB - ABIN1533846
Lekanne Deprez, Riegman, Groen, Warringa, van Biezen, Molijn, Bootsma, de Jong, Menon, Kley: Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. in Oncogene 1995
MN1 deletion is associated with Craniofacial Abnormalities.
Chromosome 22q12.1 microdeletions involving the MN1 gene confirm it as a candidate gene for cleft palate.
MLL1 and DOT1L (show DOT1L Antibodies) cooperate with meningioma-1 to induce acute myeloid leukemia (show BCL11A Antibodies).
genotype-phenotype correlation among our patients and those previously reported with overlapping 22q12 deletions, we identified a 560 kb critical region containing the MN1 gene that is implicated in human cleft palate formation
these results suggest that deregulated MN1 expression contributes to the pathogenesis of pediatric B-ALL.
identified potential driver mutations in NF2 (neurofibromatosis type 2) and MN1 (meningioma 1).
cotransduction of an activated HOX (show MSH2 Antibodies) gene (NUP98HOXD13) with MN1 induces a serially transplantable acute myeloid leukemia (show BCL11A Antibodies) (AML (show RUNX1 Antibodies)).
MN1 overexpression independently predicts bad clinical outcome in CN-AML (show RUNX1 Antibodies) patients
High MN1 expression confers worse prognosis in Chinese adult patients with de novo acute myeloid leukemia (show BCL11A Antibodies).
Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 (show TP53 Antibodies) and Bim (show BCL2L11 Antibodies) induction
Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4\\;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.
meningioma (translocation balanced)
, meningioma chromosome region 1
, probable tumor suppressor protein MN1